Jasti Property and Equity Holdings Private Limited, acting as the sole trustee of the Jasti Family Trust, has disclosed its acquisition of an additional 51,00,000 equity shares in Cohance Lifesciences Limited. This transaction represents a 1.33% increase in voting rights and a 1.26% increase in total diluted share capital. The acquisition, which occurred through inter-se transfer via Block Deals on November 9 and 11, 2026, brings the total holding of the acquirer group to 6.36% of the total share capital.
Jasti Family Trust Expands Stake in Cohance Lifesciences
Jasti Property and Equity Holdings Private Limited, acting in its capacity as the sole trustee of the Jasti Family Trust, has announced a significant acquisition of shares in Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited). The disclosure, made in accordance with SEBI regulations, details the acquisition of 51,00,000 equity shares, translating to a 1.33% increase in the acquirer’s shareholding with voting rights and a 1.26% increase in diluted share capital.
Transaction Details
The acquisition was executed through inter-se transfers via Block Deals on November 9, 2026, and November 11, 2026. Prior to this transaction, the Jasti Family Trust and associated persons acting in concert held a total of 2,43,26,009 shares, representing 6.36% of the total share capital and 5.99% of the total diluted share capital of Cohance Lifesciences Limited. Following the acquisition, the total holding by the acquirer group has increased to 2,43,26,009 shares, maintaining the overall percentage holding at 6.36% (based on updated share capital post-acquisition).
Pre and Post-Acquisition Holdings
Before the acquisition, the combined holdings of Jasti Property and Equity Holdings Private Limited (on behalf of the Trust), Jasub Property Holdings LLP, Mrs. Venkata Subbamma Jasti, Mr. Venkateswarlu Jasti, and Mrs. Sudharani Jasti amounted to 96,16,009 shares, with individual stakes and percentage contributions detailed in the disclosure. Post-acquisition, the aggregate number of shares held by the acquirer group has been adjusted to reflect the new total, with Jasti Property and Equity Holdings Private Limited now holding 45,16,009 shares.
Cohance Lifesciences Capital Structure
The total equity share capital of Cohance Lifesciences Limited before the acquisition stood at 38,25,67,140 equity shares. This capital structure remained the same after the acquisition. The total diluted share/voting capital of the company after the said acquisition/sale comprises 40,59,80,385 shares.
Source: BSE
